ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

ACLU Sues Myriad, U.S. Patent Office Over Patents For BRCA Gene Mutations

May 15, 2009

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

MRI Predicts If Chemo Working In Preoperative Therapy

February 25, 2005

In Brief: Moffitt Gets $100M From Fla. For Construction; Two Head And Neck Surgical Societies Merge

July 3, 1998

Nominations Sought For Women’s Health Achievement AwardsFor Medical Devices

February 7, 1997

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011